Tech Company Financing Transactions
Histogen Funding Round
Histogen, based in San Diego, secured $9 million from Boston Millennia Partners, Flare Capital Partners and Stryker Corporation.
Transaction Overview
Company Name
Announced On
9/4/2008
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series B
Investors
Boston Millennia Partners (Lead Investor) (Patrick Fortune)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10655 Sorrento Valley Rd.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Not Recorded
Overview
Histogen is a regenerative medicine company based on naturally-produced products from newborn fibroblasts grown in a proprietary bioreactor.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Controller
Stephen Hill
Founder
Gail Naughton
VP - Operations
Martin Latterich
VP - R & D
Michael Zimber
VP - Regulatory Affairs
Mark Hubka
Browse more venture capital transactions:
Prev: 9/3/2008: Osprey Pharmaceuticals venture capital transaction
Next: 9/4/2008: Microfabrica venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs